Title:
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
Authors:
Dror Mevorach, Emilia Anis, Tal Hasin, Michal Bromberg [et al]
Published:
The New England Journal of Medicine (NEJM), 10 March 2022
[Published as a Letter to the Editor]
From the Letter to the Editor:
Using an active nationwide surveillance system administered by the Israeli Ministry of Health, we previously found a higher incidence of myocarditis among persons 16 years of age or older who had received the BNT162b2 vaccine (Pfizer–BioNTech) than among historical controls and unvaccinated persons; the incidence was highest among young male recipients.